Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Vetr Announces Plans to Offer ToltraMax Oral Solution Upon Platform Launch

GRANTS PASS, OR, May 16, 2025 (EZ Newswire) -- Vetr, an upcoming telehealth platform focused on providing pet owners with access to veterinary products and services, has announced its intention to include ToltraMax, a toltrazuril-based oral solution, as part of its product offerings when the platform launches later this year.

ToltraMax is an oral solution formulated for use in multiple species, including dogs, cats, horses and other non food chain animals. Its active ingredient, toltrazuril, is widely used in veterinary settings to manage intestinal health challenges related to coccidia, a common protozoan parasite affecting a variety of animals.

While Vetr’s platform is still in development, ToltraMax is currently available for purchase through Amazon, Walmart, horseprerace.com, toltrazuril.com, and vetr.com, serving caretakers of equine and companion animals.

“Expanding access to essential veterinary products is a core part of Vetr’s mission,” said Andrew Hamilton, founder and CEO of Vetr. “ToltraMax aligns with our goal of providing practical, broad-use solutions and compounded drugs for pet owners and animal caretakers, making it an important addition to our future product lineup.”

Vetr aims to simplify the process of obtaining veterinary-recommended medications through a digital platform designed for convenience and accessibility. The platform will offer an online pharmacy, educational resources, and telehealth consultations, supporting responsible pet care and providing guidance on product usage.

Recently, Vetr secured $21 million in funding from Palehorse Capital to support the platform’s development and product expansion, including a nationwide online pharmacy. This investment will assist in launching a comprehensive online marketplace for veterinary products, including ToltraMax, alongside efforts to lower the overall cost of pet medications for consumers.

Upon launch, Vetr will provide pet owners with a streamlined purchasing experience, while emphasizing the importance of professional veterinary consultation. The platform will not replace veterinary care but will serve as an additional resource for accessing trusted products and information.

For updates on Vetr’s launch and product availability, visit vetr.com.

About Vetr

Vetr is a telehealth platform transforming pet healthcare by making veterinary services more affordable, accessible and efficient. Through its easy-to-use app, pet owners can schedule appointments, consult remotely with licensed veterinarians and access low-cost, over-the-counter animal prescriptions. Founded by Andrew Hamilton, Vetr is dedicated to delivering high-quality, cost-effective care for pets nationwide. With a focus on generic medications and virtual care, Vetr is redefining how modern pet owners manage their animals’ health. Learn more at vetr.com.

Media Contact

Media Relations
sales@vetr.com
###

SOURCE: Vetr

Copyright 2025 EZ Newswire

See release on EZ Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.